Cargando…
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
As the number of people infected with the newly identified 2019 novel coronavirus (SARS-CoV2) is continuously increasing every day, development of potential therapeutic platforms is vital. Based on the comparatively high similarity of receptor-binding domain (RBD) in SARS-CoV2 and SARS-CoV, it seems...
Autores principales: | Hussain, Arif, Hasan, Anwarul, Nejadi Babadaei, Mohammad Mahdi, Bloukh, Samir Haj, Chowdhury, Muhammad E.H., Sharifi, Majid, Haghighat, Setareh, Falahati, Mojtaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395593/ https://www.ncbi.nlm.nih.gov/pubmed/32768882 http://dx.doi.org/10.1016/j.biopha.2020.110559 |
Ejemplares similares
-
Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: A probable prelude to control some variants of coronavirus including Delta
por: Khan, Suliman, et al.
Publicado: (2021) -
Rapid diagnostics of coronavirus disease 2019 in early stages using nanobiosensors: Challenges and opportunities
por: Sharifi, Majid, et al.
Publicado: (2021) -
Enzyme–polymeric/inorganic metal oxide/hybrid nanoparticle bio-conjugates in the development of therapeutic and biosensing platforms
por: Khan, Suliman, et al.
Publicado: (2021) -
Polymeric-based microneedle arrays as potential platforms in the development of drugs delivery systems
por: Meng, Fansu, et al.
Publicado: (2020) -
Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens
por: Khan, Suliman, et al.
Publicado: (2023)